drugset / Trial / NCT00599443
Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years
RandomizedParallel-groupTriple-blindPrevention
Summary
A controlled, double blinded study to determine the safety and reactogenicity in healthy adults of a single dose of a trivalent cell-derived influenza vaccine administered by intramuscular injection.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seasonal cell-derived influenza vaccine | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.